Business · 02/11/2004Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for GANIRELIX ACETATE INJECTION Patent Extension
Summary
The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for GANIRELIX ACETATE INJECTION, a medication that was previously known as ANTAGON, in accordance with federal regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →